SCHEMBL24136997

SCHEMBL24136997

CCN(C)CCNNC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL254237 0.78
Hydrochloric Acid SCHEMBL21816614 0.76
SCHEMBL24773510 0.75
SCHEMBL8717205 0.74 PRMT1 (0.50)
SCHEMBL18950460 0.74 PRMT1 (0.50)
SCHEMBL29074467 0.74 PRMT1 (0.50)
SCHEMBL4270520 0.74 PRMT1 (0.50)
SCHEMBL24979647 0.72
SCHEMBL5579827 0.72 PRMT1 (0.48)
SCHEMBL10052764 0.70

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3928779-A1 PHARMACEUTICAL CONTAINING SODIUM-DEPENDENT PHOSPHATE TRANSPORTER INHIBITOR AND PHOSPHORUS ADSORBENT FOR USE IN THE PREVENTION, TREATMENT OR SUPPRESSION OF CHRONIC KIDNEY DISEASE, ARTERIOSCLEROSIS ASSOCIATED WITH VASCULAR CALCIFICATION, OR ECTOPIC CALCIFICATION. Chugai Seiyaku Kabushiki Kaisha (JP) 2021-12-29 EP disclosed